BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 239123)

  • 1. Some further observations of the effect of beta-phenethylamine on locomotor activity in mice.
    Jackson DM
    J Pharm Pharmacol; 1975 Apr; 27(4):278-80. PubMed ID: 239123
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intraventricular dopamine on the spontaneous locomotor activity of rats pretreated with nialamide, reserpine, or alpha-methyl-p-tyrosine.
    Malec D; Kleinrok Z
    Pol J Pharmacol Pharm; 1973; 25(4):357-66. PubMed ID: 4774244
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of -phenethylamine upon spontaneous motor activity in mice: a dual effect on locomotor activity.
    Jackson DM
    J Pharm Pharmacol; 1972 May; 24(5):383-9. PubMed ID: 4403808
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of catecholamines on dexamphetamine-induced changes in locomotor activity.
    Handley SL; Thomas KV
    Psychopharmacology (Berl); 1978 Jul; 58(3):283-8. PubMed ID: 98799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.
    Andén NE; Strömbom U; Svensson TH
    Psychopharmacology (Berl); 1977 Nov; 54(3):243-8. PubMed ID: 413140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of pimozide and phenoxybenzamine on the motor hyperactivity of rats treated with nialamide and dopamine (author's transl)].
    Malec D; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1975; 30():109-12. PubMed ID: 1230064
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN; Dahanukar SA; Sheth UK
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract]   [Full Text] [Related]  

  • 10. The involvement of noradrenergic systems in the locomotor activity stimulation in mice produced by beta-phenethylamine.
    Jackson DM
    J Pharm Pharmacol; 1974 Aug; 26(8):651-4. PubMed ID: 4155737
    [No Abstract]   [Full Text] [Related]  

  • 11. Morphine's proconvulsant action: importance of endogenous norepinephrine.
    Mannino RA; Wolf HH
    Life Sci; 1975 Jun; 16(11):1659-68. PubMed ID: 1142993
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-methyldopamine as a dopaminergic agonist.
    Duvoisin RC; Marsden CD
    Adv Neurol; 1975; 9():243-8. PubMed ID: 1146655
    [No Abstract]   [Full Text] [Related]  

  • 13. A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration.
    Bailey RC; Jackson DM
    Psychopharmacology (Berl); 1978 Apr; 56(3):317-26. PubMed ID: 418441
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
    Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Phenylethylamine as a possible mediator for delta9-tetrahydrocannabinol-induced stimulation.
    Sabelli HC; Vazquez AJ; Mosnaim AD; Madrid-Pedemonte L
    Nature; 1974 Mar; 248(5444):144-5. PubMed ID: 4274244
    [No Abstract]   [Full Text] [Related]  

  • 16. Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.
    Dunstan R; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):153-6. PubMed ID: 209350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copulatory behavior in the male rat after impaired monoaminergic neurotransmission.
    Malmnäs CO
    Acta Physiol Scand Suppl; 1973; 400():69-95. PubMed ID: 4136131
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 19. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of reserpine, tranylcypromine, haloperidol and FLA-63 on physostigmine--induced hyperactivity in rats.
    Wray SR; Egbe PC
    West Indian Med J; 1980 Mar; 29(1):60-6. PubMed ID: 7385820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.